Wellster completes series B with $60M to launch FemTech platform
Wellster Healthtech Group, Europe’s leading digital healthcare platform, announces today a further $20M in funding, just six months after raising a $40M. With this, Wellster closes its series B.
The latest funding is provided by Claret Capital, an investor in the FemTech platform Bellabeat and Europe and Israel tech VC Mangrove Capital Partners whose other healthtech investments include K Health ($1.5B valuation) and Flo ($800M valuation). This investment cements Wellster’s position as Europe’s best-funded integrated healthcare company.